Concepedia

Parul Doshi

PD

34

Publications

2.7K

Citations

23

H-Index

1991

Active since

Affiliations

Janssen (United States)(Current)

Bristol-Myers Squibb (United States)

Icahn School of Medicine at Mount Sinai

Emory University

Genmab (Netherlands)

Parul Doshi is an author at Janssen (United States) specializing in medicine, immunology, and radiation oncology.

ORCID

Top concepts

Publications per year

1991–2025

34

Publications

34

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆

David R. Spigel, David Vicente, Tudor–Eliade Ciuleanu et al. · Annals of Oncology · 2021 · 263 citations · Full text

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab

Inger S. Nijhof, Richard W.J. Groen, H M Lokhorst et al. · Leukemia · 2015 · 261 citations · Full text

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Taofeek K. Owonikoko, Keunchil Park, Ramaswamy Govindan et al. · Journal of Clinical Oncology · 2021 · 254 citations · Full text

Resolving the daratumumab interference with blood compatibility testing

Claudia I. Chapuy, Rachel T. Nicholson, Maria Aguad et al. · Transfusion · 2015 · 232 citations · Full text

STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort

Simon Papillon‐Cavanagh, Parul Doshi, Radu Dobrin et al. · ESMO Open · 2020 · 227 citations · Full text

Rows per page

1–5 of 34